Cirugía en medicina general: manual de enfermedades quirúrgicas

165 Capítulo 15 / Neoplasias Gástricas, Parte I NCCN. (27 de Marzo de 2018). National Comprehensive Cancer Network, Soft Tissue Sarcoma Clinical Guidelines in Oncology. Obtenido de NCCN.org . Nilsson, B. a. (2005). Gastrointestinal Stromal Tumors: The incidence, prevalence, clinical course and prognostication in the preimatinib mesylate era- a population based study in western Sweden. Cancer, 821-9. Oberndorfer, S. (1907). Karzinoide tumoren des Dünndarms. Frankf Z Pathol, 425-432. Palnaes, C., Holst, I., & Knigge, U. (2015). Gastrointestinal Surgery of Neuroendocrine Neoplasms. Front Horm Res. Basel, Karger, 149-163. Patrikidou, A., Domont, J., & Chabaud, S. (2016). Long-term outcome of molecular subgroups of GIST patient treated with standard-dose Imatinib in the BRF14 trial of the french sarcoma group. Eur J Cancer, 173-180. Pérez, G. y. (2018). Revisión de la poliposis gástrica: a propósito de una caso operado por laparoscopía con protocolo fast track. Revista Chilena de Cirugía, 160-163. R Basuroy, R. S. (2014). Review article: the investigation and management of gastric neuroendocrine tumours. Alimentary Pharmacology and therapeutics, 1071-1084. Rindi G, L. O. (1993). Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathological study. Gastroenterology, 994-1006. Salas, A. (2007). Evaluación de la displasia en las enfermedades digestivas. Gastroenterol Hepatol, 602-11. Shaib, Y. a. (2013). Perspectives in clinical gastroenterology and hepatology: Management of gastric polyps, an endoscopy- based approach. Clin Gastroenterol Hepatol, 1374-1384. Siaw M Chai, I. S. (2018). Gastroenteropancreatic neuroendocrine neoplasms: Selected pathology review and molecular updates. Histopathology, 153-167. Silvia Uccella, S. L. (2018). Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary and Thymic Neuroendocrine Neoplasms. Endocrine Pathology. Sociedad Argentina de Hematología. (2017). Guías de Diagnóstico y tratamiento de Linfomas. Buenos Aires. Sung, J. (2016). Diagnosis and management of gastric dysplasia. Korean J Intern Med, 201-209. Swerdlow, S. y. (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 2375-90. Thieblemont, C., & Zucca, E. (2017). Clinical aspects and therapy of gastrointestinal MALT lymphoma. Best Practice and Research Clinical Haematology, 109-117. Virmani, V. e. (2012). Neoplastic stomach lesions and their mimickers: spectrum of imaging manifestations. Cancer Imaging, 269-278. Von Mehren, M., Heinrich, M., & Joensuu, H. (2011). Follow- up results after 9 years of the ongoing, phase II B2222 trial of Imatinib mesylate in patients with metastatic or unresectable KIT + GIST. J Clin Oncol. Webb, R., Brant, W., & Major, N. (2010). TAC body. Madrid: Marbán. World Health Organization. (2000). International Classification of Diseases for Oncology, Third Edition. Geneva. Yu, Q., He, Z., &Wang, J. (2014). Clinical Presentations of Gastric Small Gastrointestinal Stromal Tumors mimics functional dispepsia symptoms. World J Gastroenterol.